Lorbriqua 25mg Tablet
Prescription Required
Product introduction
Lorbriqua 25mg Tablet is used to treat adults with unresectable (unremovable), advanced, or recurrent forms of non-small cell lung cancer (NSCLC). It works by inhibiting an enzyme called anaplastic lymphoma kinase (ALK) and is given to patients who have an alteration in this enzyme.
Lorbriqua 25mg Tablet is used to treat different types of cancer
Lorbriqua 25mg Tablet is used to treat different types of cancer
Uses of Lorbriqua Tablet
Benefits of Lorbriqua Tablet
In Treatment of Non-small cell lung cancer
Lorbriqua 25mg Tablet helps shrink the tumor size and restricts the spread of cancer to other parts of the body. This medicine can effectively treat cancer that has spread to the brain because it can cross the blood-brain barrier. This barrier is a network of blood and tissue that prevents infectious bacteria and other harmful substances from entering the brain. The use of Lorbriqua 25mg Tablet helps prevent disease progression and reduce the chances of recurrence over a long period.
Side effects of Lorbriqua Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Lorbriqua
- Fatigue
- Diarrhea
- Edema (swelling)
- High blood pressure
- Cough
- Joint pain
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Weight gain
- Breathlessness
- Mood changes
- Hypercholesterolemia (high cholesterol)
- Increased triglyceride level in blood
How to use Lorbriqua Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lorbriqua 25mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
How Lorbriqua Tablet works
Lorbriqua 25mg Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Lorbriqua 25mg Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Lorbriqua 25mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CAUTION
Lorbriqua 25mg Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving
CONSULT YOUR DOCTOR
It is not known whether Lorbriqua 25mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
CAUTION
Lorbriqua 25mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Lorbriqua 25mg Tablet may be needed. Please consult your doctor.
However, no dose adjustment is recommended for patients with mild or moderate renal impairment.
However, no dose adjustment is recommended for patients with mild or moderate renal impairment.
Liver
SAFE IF PRESCRIBED
Lorbriqua 25mg Tablet is safe to use in patients with liver disease. No dose adjustment of Lorbriqua 25mg Tablet is recommended.
However, recommended dosage regimen has not been established in cases of moderate to severe hepatic impairment.
However, recommended dosage regimen has not been established in cases of moderate to severe hepatic impairment.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Fact Box
Chemical Class
Phenylpropanoid derivatives
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Tyrosine kinase inhibitors
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.Marketer details
Name: Pfizer Ltd
Address: The Capital, 1802, 18th Floor , Plot No. C-70, ‘G’ Block , Bandra Kurla Complex, Bandra East , Mumbai – 400051.
Country of origin: Germany
Expires on or after: February, 2025
A licensed vendor partner from your nearest location will deliver Lorbriqua 25mg Tablet. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.
Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India
Expires on or after: February, 2025
A licensed vendor partner from your nearest location will deliver Lorbriqua 25mg Tablet. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.
In case of any issues, contact us
Email ID: [email protected]Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India
Lab tests offered by us
Related/Popular tests
MRP
₹51000
Inclusive of all taxes
1 Strip
15.0 tablets in 1 strip
Variants (2)